Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Effectiveness of Slip Resistant Footwear in Dairy Industry

NCT07280988 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2025-09-01
Last updated
2025-12-15

Condition(s) studied

SlipsFalls PreventionPerceived Slipperiness

Investigational drug(s) / intervention(s)

Environment specific safety footwear

Environment specific safety footwear: The participants will wear two different safety shoes (SIKA Highline and AIRTOX FW44) in the test periode (20 working days). 10 working days in each safety shoes.

Study summary

In the dairy industry, same-level falls are a major problem and a well-known challenge. At Arla's dairy in Taulov, where this RCT study is being carried out, reports of risk observations, near incidents, and workplace accidents have increased over the past five years. Accident statistics further show that same-level falls are the most common incidents, with slippery floors and surfaces being by far the main cause of both near incidents and risk observations. Because of this, it is necessary to test different types of safety footwear that, based on laboratory studies, are considered particularly suitable for the working environment in a dairy.

it is hypothesized that employees, through subjective questionnaires, will rate one shoe as less slippery than the other. At the same time, it is hypothesized that employees will also subjectively find one shoe more comfortable than the other.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Full-time employed at Arla Taulov dairy facility. * No major injuries affecting their daily work. * No plans of retiring before the end of the study period. Exclusion Criteria: * Surgery in the feet and under extremity within the last three months. Pregnancy. * Part-time workers. * Neurological disorders affecting gait. * Can read and understand Danish

Primary outcome measure(s)

  • Self-reported feel of slipperines — Through study completion, an average of 20 working days
    Self-rated feel of slipperiness. "To what extent did you feel the need to walk carefully today?" Rated on a continuous VAS scale (not slippey to the right and slippery to the left). Less slippery towards right and most slippery towards left. Hence, towards right is better. These are obtained with daily questionaries.

Trial sites (1)

FacilityCityRegionStatus
Arla Foods AMBA Taulov Denmark
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07280988 on ClinicalTrials.gov ↗ ← All trials in Denmark